NDC 71335-2433-01 - CHLORZOXAZONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-2433
- Requested NDC
- 71335-2433-01
- Package NDCs from labels
- 71335-2433-1, 71335-2433-2, 71335-2433-3, 71335-2433-4, 71335-2433-5, 71335-2433-6, 71335-2433-7, 71335-2433-8, 71335-2433-9, 71335-2433-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHLORZOXAZONE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2433-1 | CHLORZOXAZONE | 20 in 1 BOTTLE | TABLET | 20 | 2 | |
| 71335-2433-2 | CHLORZOXAZONE | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 71335-2433-3 | CHLORZOXAZONE | 40 in 1 BOTTLE | TABLET | 40 | 2 | |
| 71335-2433-4 | CHLORZOXAZONE | 90 in 1 BOTTLE | TABLET | 90 | 2 | |
| 71335-2433-5 | CHLORZOXAZONE | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 71335-2433-6 | CHLORZOXAZONE | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 71335-2433-7 | CHLORZOXAZONE | 14 in 1 BOTTLE | TABLET | 14 | 2 | |
| 71335-2433-8 | CHLORZOXAZONE | 7 in 1 BOTTLE | TABLET | 7 | 2 | |
| 71335-2433-9 | CHLORZOXAZONE | 120 in 1 BOTTLE | TABLET | 120 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-2433 | CHLORZOXAZONE TABLET [BRYANT RANCH PREPACK] | 2 | Current NDC, 9 package rows | 20240910_d7f09907-83b2-46cf-947d-fa38dcf88685.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-2433-5 | EA - Each | 71335-2433 | 4d6bd30c-ee67-4eec-9173-97dc81acd5cd | 1 | 2025-10-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 4180a35b-cc50-46ae-a100-99bb218c10ff | 2026-09-09 | Warnings | F05Q2T2JA0 |
| Kroger Stool Softener Fruit Punch | DOCUSATE SODIUM | KROGER COMPANY | b86f8f3d-594e-466c-854a-b8bff9f7a0b8 | 2026-09-02 | Warnings | F05Q2T2JA0 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Preferred Pharmaceuticals, Inc. | b25b8a28-5e00-4a20-9ca3-7ed494fc4540 | 2026-09-01 | Warnings | F05Q2T2JA0 |
| Chlorzoxazone | CHLORZOXAZONE | Par Health USA, LLC | 7c5a835d-3754-4c25-a0e2-335b8eceb2d2 | 2026-08-31 | Warnings, Adverse reactions | 1088936 1088934 H0DE420U8G |
| HyVee Senna S | DOCUSATE SODIUM, SENNOSIDES | HyVee Inc | 4982b9c6-ed0e-24da-e063-6394a90a147f | 2026-08-24 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | ccec364a-3135-4a5d-b4b0-86b832387b4e | 2026-08-24 | Warnings | F05Q2T2JA0 |
| Colace | DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | a1591da0-a1a9-9583-3cf5-788b8fee3814 | 2026-08-24 | F05Q2T2JA0 | |
| HyVee Senna S | DOCUSATE SODIUM, SENNOSIDES | HyVee Inc | 49837b2c-492f-2fed-e063-6294a90aaa24 | 2026-08-21 | Warnings | F05Q2T2JA0 |
| Senokot-S | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | c24cdc5e-62e0-41a6-8afb-512202a569f4 | 2026-08-21 | Warnings | F05Q2T2JA0 |
| Foster and Thrive Senna-S Sennosides and Docusate Sodium Laxative and Stool Softener | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Strategic Sourcing Services LLC | 5966ff80-7be2-788a-e063-6294a90ab4f3 | 2026-08-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | Safeway, Inc. | ae2c7300-f9c4-43b5-9f8e-30f2e7d17635 | 2026-08-19 | Warnings | F05Q2T2JA0 |
| CVS Stool Softener Fruit Punch | DOCUSATE SODIUM | CVS PHARMACY, INC | 0e6900d6-7dc9-47d6-a006-1695feb8d5a5 | 2026-08-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 306fd12b-ed60-40dc-a5be-2dc394bd29d2 | 2026-08-17 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | Morepen Bio Inc | 562d1b9a-09d8-92fc-e063-6394a90a1993 | 2026-08-14 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | f4671579-aed0-4f93-ab83-248e0d72b5b0 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | Aldama Pharmaceuticals, Inc | 492b6d37-47cf-3a28-e063-6294a90a2a18 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Shield Pharmaceuticals Corp | 0be906d8-3db5-4218-bbdf-f1d126007990 | 2026-08-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 4e97dd60-96e3-4b51-b614-c62480af1919 | 2026-08-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 098d2377-0019-45fe-b995-700b1b1241c4 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Docusate Sodium softgels 50mg (Dye Free) | DOCUSATE SODIUM | CVS Pharmacy | 273ea95f-3c9c-98e8-e063-6294a90a2135 | 2026-08-05 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.